Radiomic Signatures Associated with CD8 + Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study.
Simple Summary: Immune checkpoint inhibitors can be effective drugs to treat cancer. However, only a minority of patients derive benefits. An important determinant of treatment success is the abundance of CD8-expressing tumour-infiltrating lymphocytes (CD8+ TILs) in target tumours. The measurement o...
| Publicado en: | Cancers Vol. 14; no. 15; pp. 3656 - 3678 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | pictorial research systematic review tables/charts Journal Article |
| Publicado: |
MDPI
Aug2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |